Science and Research

Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood

BACKGROUND: Hermansky-Pudlak syndrome (HPS), a hereditary multisystem disorder with oculocutaneous albinism, may be caused by mutations in one of at least 10 separate genes. The HPS-2 subtype is distinguished by the presence of neutropenia and knowledge of its pulmonary phenotype in children is scarce. METHODS: Six children with genetically proven HPS-2 presented to the chILD-EU register between 2009 and 2017; the data were collected systematically and imaging studies were scored blinded. RESULTS: Pulmonary symptoms including dyspnea, coughing, need for oxygen, and clubbing started 3.3 years before the diagnosis was made at the mean age of 8.83 years (range 2-15). All children had recurrent pulmonary infections, 3 had a spontaneous pneumothorax, and 4 developed scoliosis. The frequency of pulmonary complaints increased over time. The leading radiographic pattern was ground-glass opacities with a rapid increase in reticular pattern and traction bronchiectasis between initial and follow-up Computer tomography (CT) in all subjects. Honeycombing and cysts were newly detectable in 3 patients. Half of the patients received a lung biopsy for diagnosis; histological patterns were cellular non-specific interstitial pneumonia, usual interstitial pneumonia-like, and desquamative interstitial pneumonia. CONCLUSIONS: HPS-2 is characterized by a rapidly fibrosing lung disease during early childhood. Effective treatments are required.

  • Hengst, M.
  • Naehrlich, L.
  • Mahavadi, P.
  • Grosse-Onnebrink, J.
  • Terheggen-Lagro, S.
  • Skanke, L. H.
  • Schuch, L. A.
  • Brasch, F.
  • Guenther, A.
  • Reu, S.
  • Ley-Zaporozhan, J.
  • Griese, M.

Keywords

  • Childhood
  • Hermansky-Pudlak syndrome type 2
  • Pulmonary fibrosis
  • Pulmonary phenotype
  • Tachydyspnea
Publication details
DOI: 10.1186/s13023-018-0780-z
Journal: Orphanet journal of rare diseases
Pages: 42 
Number: 1
Work Type: Original
Location: CPC-M, UGMLC
Disease Area: CFBE
Partner / Member: JLU, LMU
Access-Number: 29580292
See publication on PubMed

DZL Engagements

chevron-down